• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经股动脉与桡动脉入路行经皮冠状动脉介入治疗左主干病变:来自退伍军人事务部临床、报告和跟踪项目的分析。

Radial versus femoral access for left main percutaneous coronary intervention: An analysis from the Veterans Affairs Clinical, Reporting, and Tracking Program.

机构信息

Section of Cardiology, Harry S. Truman VA Hospital, Columbia, Missouri, USA.

Division of Cardiovascular Disease, Department of Medicine, University of Missouri, Columbia, Missouri, USA.

出版信息

Catheter Cardiovasc Interv. 2022 Feb;99(2):480-488. doi: 10.1002/ccd.30024. Epub 2021 Nov 30.

DOI:10.1002/ccd.30024
PMID:34847279
Abstract

OBJECTIVES

We aimed to compare clinical characteristics and procedural outcomes of left main percutaneous interventions (LM-PCI) by transradial (TRA) versus transfemoral (TFA) approach in the VA healthcare system.

BACKGROUND

TRA for percutaneous coronary intervention (PCI) is steadily increasing. However, the frequency and efficacy of TRA for LM-PCI remain less studied.

METHODS

All LM-PCIs performed in the VA healthcare system were identified for fiscal year 2008 through 2018. Patients' baseline characteristics and procedure-related variables were compared by access site. Both short- and long-term clinical outcomes were analyzed using propensity score matching.

RESULTS

A total of 4004 LM-PCI were performed in the VA via either radial or femoral access from 2008 to 2018. Among these, 596 (14.9%) LM PCIs were performed via TRA. Use of TRA for LM-PCI increased from 2.2% to 31.5% over the study period. Propensity matched outcome analysis, comparing TRA versus TFA, showed a similar procedural success (98.4% for TRA vs. 97.8% for TFA; RR: 1.01 [0.98, 1.03]) and 1-year major adverse cardiovascular events (MACE) (25.9% for TRA vs. 26.8% TFA; RR: 0.96 [0.74, 1.25]). There were no statistically significant differences among secondary outcomes analyses including major bleeding.

CONCLUSION

Use of TRA for LM-PCI has been steadily increasing in the VA healthcare system. These findings demonstrate similar procedural success and 1-year MACE across access strategies, suggesting an opportunity to continue increasing TRA use for LM-PCI.

摘要

目的

我们旨在比较经桡动脉(TRA)和经股动脉(TFA)途径行左主干经皮冠状动脉介入治疗(LM-PCI)的临床特征和手术结果。

背景

经皮冠状动脉介入治疗(PCI)的 TRA 使用率稳步上升。然而,TRA 行 LM-PCI 的频率和疗效仍研究较少。

方法

确定了 2008 年至 2018 年期间在退伍军人事务部医疗保健系统中进行的所有 LM-PCI。通过入路比较患者的基线特征和与手术相关的变量。采用倾向性评分匹配分析短期和长期临床结局。

结果

2008 年至 2018 年期间,通过桡动脉或股动脉在退伍军人事务部共进行了 4004 例 LM-PCI。其中,596 例(14.9%)LM PCI 通过 TRA 进行。在研究期间,TRA 用于 LM-PCI 的比例从 2.2%增加到 31.5%。TRA 与 TFA 的倾向性匹配结果分析显示,手术成功率相似(TRA 为 98.4%,TFA 为 97.8%;RR:1.01[0.98,1.03]),1 年主要不良心血管事件(MACE)发生率相似(TRA 为 25.9%,TFA 为 26.8%;RR:0.96[0.74,1.25])。次要结局分析中,包括大出血,均无统计学差异。

结论

TRA 用于 LM-PCI 的使用率在退伍军人事务部医疗保健系统中稳步上升。这些发现表明,不同入路策略的手术成功率和 1 年 MACE 相似,表明有机会继续增加 TRA 用于 LM-PCI 的使用率。

相似文献

1
Radial versus femoral access for left main percutaneous coronary intervention: An analysis from the Veterans Affairs Clinical, Reporting, and Tracking Program.经股动脉与桡动脉入路行经皮冠状动脉介入治疗左主干病变:来自退伍军人事务部临床、报告和跟踪项目的分析。
Catheter Cardiovasc Interv. 2022 Feb;99(2):480-488. doi: 10.1002/ccd.30024. Epub 2021 Nov 30.
2
Left main percutaneous coronary intervention-Radial versus femoral access: A systematic analysis.左主干经皮冠状动脉介入治疗-桡动脉与股动脉入路:系统分析。
Catheter Cardiovasc Interv. 2020 Jun 1;95(7):E201-E213. doi: 10.1002/ccd.28451. Epub 2019 Aug 20.
3
Transradial Versus Transfemoral Access for Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery Stenosis: A Systematic Review and Meta-Analysis.经桡动脉与经股动脉途径用于无保护左主干冠状动脉狭窄的经皮冠状动脉介入治疗:一项系统评价和荟萃分析。
Cardiovasc Revasc Med. 2019 Sep;20(9):790-798. doi: 10.1016/j.carrev.2018.10.025. Epub 2018 Nov 3.
4
Outcomes of Transradial PCI compared to Transfemoral PCI in veterans with anemia: Insight from the VA Clinical Assessment, Reporting and Tracking (CART) program.退伍军人贫血患者经桡动脉与经股动脉冠状动脉介入治疗的结局:来自退伍军人事务部临床评估、报告和跟踪(CART)项目的见解
Cardiovasc Revasc Med. 2019 Nov;20(11):990-996. doi: 10.1016/j.carrev.2019.01.014. Epub 2019 Jan 14.
5
Outcomes of Transradial Approach to Percutaneous Coronary Intervention in End-Stage Renal Disease Patients on Dialysis.经皮冠状动脉介入治疗在终末期肾病透析患者中的桡动脉入路治疗效果。
Cardiovasc Revasc Med. 2020 Sep;21(9):1131-1135. doi: 10.1016/j.carrev.2020.01.017. Epub 2020 Jan 25.
6
Impact of Access Site Practice on Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention Following Thrombolysis for ST-Segment Elevation Myocardial Infarction in the United Kingdom: An Insight From the British Cardiovascular Intervention Society Dataset.英国经溶栓治疗的 ST 段抬高型心肌梗死患者行经皮冠状动脉介入治疗中穿刺部位操作对临床结局的影响:来自英国心血管介入学会数据集的见解。
JACC Cardiovasc Interv. 2017 Nov 27;10(22):2258-2265. doi: 10.1016/j.jcin.2017.07.049.
7
Operator learning curve for transradial percutaneous coronary interventions: implications for the initiation of a transradial access program in contemporary US practice.经桡动脉冠状动脉介入治疗的术者学习曲线:对当代美国实践中开展经桡动脉入路项目的启示
Cardiovasc Revasc Med. 2014 Jun;15(4):195-9. doi: 10.1016/j.carrev.2014.03.001. Epub 2014 Mar 13.
8
Full conversion from transfemoral to transradial approach for percutaneous coronary interventions results in a similar success rate and a rapid reduction of in-hospital cardiac and vascular major events.经股动脉入路完全转为经桡动脉入路行经皮冠状动脉介入治疗可获得相似的成功率,并可迅速减少住院期间心脏和血管主要不良事件。
EuroIntervention. 2013 Jul;9(3):345-52. doi: 10.4244/EIJV9I3A56.
9
Transradial versus transfemoral approach for percutaneous coronary intervention in patients with ST-elevation myocardial infarction complicated by cardiogenic shock: a systematic review and meta-analysis.经桡动脉入路与经股动脉入路在伴心原性休克的 ST 段抬高型心肌梗死患者经皮冠状动脉介入治疗中的比较:系统评价和荟萃分析。
Eur Heart J Qual Care Clin Outcomes. 2022 Sep 5;8(6):640-650. doi: 10.1093/ehjqcco/qcac018.
10
Long-term clinical outcomes in transradial versus transfemoral access for left main percutaneous coronary intervention.经桡动脉与经股动脉入路行左主干经皮冠状动脉介入治疗的长期临床结局。
Catheter Cardiovasc Interv. 2021 May 1;97 Suppl 2:1009-1015. doi: 10.1002/ccd.29586. Epub 2021 Mar 10.

引用本文的文献

1
Revealing concealed cardioprotection by platelet Mfsd2b-released S1P in human and murine myocardial infarction.揭示血小板 Mfsd2b 释放的 S1P 在人类和鼠心肌梗死中的隐匿性心脏保护作用。
Nat Commun. 2023 Apr 26;14(1):2404. doi: 10.1038/s41467-023-38069-5.